Article Information
PubMed
Print ISSN
Online ISSN
History
- Received October 31, 2007
- Accepted December 19, 2007
- Published online February 22, 2008.
Article Versions
- Earlier version (December 20, 2007 - 08:08).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Christine Healan-Greenberg,
- Jeffrey F. Waring,
- Dale J. Kempf,
- Eric A. G. Blomme,
- Rommel G. Tirona and
- Richard B. Kim
- Abbott Laboratories, Global Pharmaceutical Research and Development, Abbott Park, Illinois (C.H.-G., J.F.W., D.J.K., E.A.G.B.); and Division of Clinical Pharmacology, Department of Medicine and Department of Physiology & Pharmacology, the University of Western Ontario, Schulich School of Medicine & Dentistry, London, Ontario, Canada (R.G.T., R.B.K.)
- Address correspondence to:
Dr. Jeffrey F. Waring, Molecular and Cellular Toxicology, Abbott Laboratories Bldg. AP9A R463, 100 Abbott Park Road, Abbott Park, IL 60064-6104. E-mail: jeff.waring{at}abbott.com
Statistics from Altmetric.com
Article usage
In this issue
A Human Immunodeficiency Virus Protease Inhibitor Is a Novel Functional Inhibitor of Human Pregnane X Receptor
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement